. Ropivacaine treatment does not affect the viability of AC16 and HCM cells. Cell viability following treatment with different ropivacaine concentrations. Data are presented as the mean ± standard deviation from three independent experiments. Figure S2 . Ropivacaine treatment does not alter the effects of propofol on the viability of AC16 and HCM cells. Cell viability following combined treatment with 25 µg/ml of propofol and different ropivacaine concentrations. Data are presented as the mean ± standard deviation from three independent experiments. *** Figure S3 . Ropivacaine treatment does not change the CoCl 2 -induced hypoxic effects on the viability of AC16 and HCM cells. Cell viability following the combined treatment with 500 µm CoCl 2 and different ropivacaine concentrations. Data are presented as the mean ± SD from three independent experiments. ** P<0.01 vs. the control group. Con, control; NS, not significant; CoCl 2 , cobalt chloride. Figure S4 . Western blot analyses of the phosphorylation of p65, p38, ERK and JNK in AC16 and HCM cells. AC16 and HCM cells were pre-incubated with propofol at different concentrations at 37˚C for 2 h. P, phosphorylated.
